FOLFIRI Followed by FOLFOX6 or the Reverse Sequence in Advanced Colorectal Cancer: A Randomized GERCOR Study von TOURNIGAND, Christophe, ANDRE, Thierry, LANDI, Bruno, COLIN, Philippe, LOUVET, Christophe, DE GRAMONT, Aimery, ACHILLE, Emmanuel, LLEDO, Gérard, FLESH, Michel, MERY-MIGNARD, Dominique, QUINAUX, Emmanuel, COUTEAU, Corinne, BUYSE, Marc, GANEM, Gérard

Volltext

A Phase I Study of Irinotecan As a 3-Week Schedule in Children With Refractory or Recurrent Solid Tumors von VASSAL, Gilles, DOZ, Francois, PEIN, Francois, FRAPPAZ, Didier, IMADALOU, Karima, SICARD, Evelyne, SANTOS, Alexandre, O'QUIGLEY, John, GERMA, Caroline, RISSE, Marie-Laure, MIGNARD, Dominique

Volltext

Randomized Multicenter Phase II Study Comparing a Combination of Fluorouracil and Folinic Acid and Alternating Irinotecan and Oxaliplatin With Oxaliplatin and Irinotecan in Fluorou... von BECOUARN, Yves, GAMELIN, Erick, BEKRADDA, Mohamed, MIGNARD, Dominique, MOUSSEAU, Mireille, COUDERT, Bruno, NEGRIER, Sylvie, PIERGA, Jean-Yves, RAOUL, Jean-Luc, PROVENCAL, Jocelyne, RIXE, Olivier, KRISCH, Claude, GERMA, Caroline

Volltext

FOLFIRI Followed by FOLFOX6 or the Reverse Sequence in Advanced Colorectal Cancer: A Randomized GERCOR Study von Tournigand, Christophe, André, Thierry, Achille, Emmanuel, Lledo, Gérard, Flesh, Michel, Mery-Mignard, Dominique, Quinaux, Emmanuel, Couteau, Corinne, Buyse, Marc, Ganem, Gérard, Landi, Bruno, Colin, Philippe, Louvet, Christophe, de Gramont, Aimery

Volltext

Combination of Oxaliplatin Plus Irinotecan in Patients With Gastrointestinal Tumors: Results of Two Independent Phase I Studies With Pharmacokinetics von Wasserman, Ernesto, Cuvier, Caroline, Lokiec, François, Goldwasser, François, Kalla, Salima, Méry-Mignard, Dominique, Ouldkaci, Mahmoud, Besmaine, Amine, Dupont-André, Ghislaine, Mahjoubi, Mondher, Marty, Michel, Misset, Jean-Louis, Cvitkovic, Esteban

Volltext

Irinotecan Combined With Bolus Fluorouracil, Continuous Infusion Fluorouracil, and High-Dose Leucovorin Every Two Weeks (LV5FU2 Regimen): A Clinical Dose-Finding and Pharmacokineti... von DUCREUX, M, YCHOU, M, SEITZ, J.-F, BONNAY, M, BEXON, A, ARMAND, J.-P, MAHJOUBI, M, MERY-MIGNARD, D, ROUGIER, P

Volltext

A Phase II study of irinotecan in patients with advanced renal cell carcinoma von Fizazi, Karim, Rolland, Frédéric, Chevreau, Christine, Droz, Jean‐Pierre, Mery‐Mignard, Dominique, Culine, Stéphane, Escudier, Bernard

Volltext

Results of a European Organization for Research and Treatment of Cancer/Early Clinical Studies Group Phase II Trial of First-Line Irinotecan in Patients With Advanced or Recurrent... von LHOMME, C, FUMOLEAU, P, LENTZ, M.-A, VAN GLABBEKE, M, MATTHIEU-BOUE, A, MIGNARD, D, CHEVALLIER, B, FARGEOT, P, KRAKOWSKI, Y, DIERAS, V, CHAUVERGNE, J, VENNIN, P, REBATTU, P, ROCHE, H, MISSET, J.-L

Volltext

A dose finding, safety and pharmacokinetic study of AVE1642, an anti-insulin-like growth factor-1 receptor (IGF-1R/CD221) monoclonal antibody, administered as a single agent and in... von Soria, Jean Charles, Massard, Christophe, Lazar, Vladimir, Ozoux, Marie-Laure, Mery-Mignard, Dominique, Deslandes, Antoine, Tolcher, Anthony W

Volltext

Circadian Rhythm of Irinotecan Tolerability in Mice von Filipski, Elisabeth, Lemaigre, Guy, Liu, Xu-Hui, Méry-Mignard, Dominique, Mahjoubi, Mondher, Lévi, Francis

Volltext

High prognostic significance of residual disease after neoadjuvant chemotherapy : a retrospective study in 710 patients with operable breast cancer von AMAT, Sophie, ABRIAL, Catherine, CURE, Hervé, CHOLLET, Philippe, PENAULT-LLORCA, Frédérique, DELVA, Rémi, BOUGNOUX, Philippe, LEDUC, Bernard, MOURET-REYNIER, Marie-Ange, MERY-MIGNARD, Dominique, BLEUSE, Jean-Pierre, DAUPLAT, Jacques

Volltext

Irinotecan as first-line chemotherapy in patients with advanced hepatocellular carcinoma: A multicenter phase II study with dose adjustment according to baseline serum bilirubin le... von Boige, Valérie, Taïeb, Julien, Hebbar, Mohamed, Malka, David, Debaere, Thierry, Hannoun, Laurent, Magherini, Emmanuelle, Mignard, Dominique, Poynard, Thierry, Ducreux, Michel

Volltext

Abstract A134: Pharmacokinetics and metabolism of iniparib for the treatment of metastatic triple-negative breast cancer (TNBC) von Verweij, Jaap, Dieras, Veronique, Rockich, Kevin, Su, Yaming, Mery-Mignard, Dominique, Pham, Nga, Emmons, Gary

Volltext

Pathophysiology and therapy of irinotecan-induced delayed-onset diarrhea in patients with advanced colorectal cancer: a prospective assessment von SALIBA, F, HAGIPANTELLI, R, CVITKOVIC, E, MISSET, J.-L, BASTIAN, G, VASSAL, G, BONNAY, M, HERAIT, P, COTE, C, MAHJOUBI, M, MIGNARD, D

Volltext

Phase I Study of AVE1642 Anti IGF-1R Monoclonal Antibody in Patients with Advanced Multiple Myeloma von Moreau, Philippe, Hulin, Cyrille, Facon, Thierry, Boccadoro, Mario, Mery-Mignard, Dominique, Deslandes, Antoine, Harousseau, Jean-Luc

Volltext

A pilot study of antioxidant potential of endophytic fungi from some Sudanese medicinal plants von Khiralla, Afra, Mohamed, Ietidal, Thomas, Justinne, Mignard, Benoît, Spina, Rosella, Yagi, Sakina, Laurain-Mattar, Dominique

Volltext

Use of Anti-MUC1 Maytansinoid Immunoconjugate Antibody for the Treatment of Solid Tumors von Assadourian Sylvie, Mignard Dominique

Volltext bestellen

High Prognostic Significance of Residual Disease After Neoadjuvant Chemotherapy: a Retrospective Study in 710 Patients with Operable Breast Cancer von Abrial, Sophie Catherine, Penault-Llorca, Frédérique, Delva, Rémi, Bougnoux, Philippe, Leduc, Bernard, Mouret-Reynier, Marie-Ange, Mery-Mignard, Dominique, Bleuse, Jean-Pierre, Dauplat, Jacques, Curé, Hervé, Chollet, Philippe

Volltext

USE OF ANTI-MUC1 MAYTANSINOID IMMUNOCONJUGATE ANTIBODY FOR THE TREATMENT OF SOLID TUMORS von MIGNARD, Dominique, ASSADOURIAN, Sylvie

Volltext bestellen

Use of anti-MUC1 maytansinoid immunoconjugate antibody for the treatment of solid tumors von ASSADOURIAN, SYLVIE, MIGNARD, DOMINIQUE

Volltext bestellen